Problem Drug-related Behavior and Discontinuation of Opioids Following the Introduction of an Opioid Management Program

References

1. 1.↵
   Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep 2011;60:1487–92.

   OpenUrlPubMed
2. 2.↵
   1. Chou R,
   2. Fanciullo GJ,
   3. Fine PG,
   4. et al

   ; American Pain Society–American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113–30.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   Federation of State Medical Boards. Model policy on the use of opioid analgesics in the treatment of chronic pain. Available from: http://www.fsmb.org/Media/Default/PDF/FSMB/Advocacy/pain_policy_july2013.pdf. Accessed June 26, 2016.
4. 4.↵
   Washington State Agency Medical Directors Group (AMDG). Interagency guideline on prescribing opioids for pain. Available from: http://www.agencymeddirectors.wa.gov/Files/2015AMDGOpioidGuideline.pdf. Accessed June 26, 2016.
5. 5.↵
   1. Johnson H,
   2. Paulozzi L,
   3. Porucznik C,
   4. Mack K,
   5. Herter B

   ; Hal Johnson Consulting and Division of Disease Control and Health Promotion, Florida Department of Health. Decline in drug overdose deaths after state policy changes - Florida, 2010–2012. MMWR Morb Mortal Wkly Rep 2014;63:569–74.

   OpenUrlPubMed
6. 6.↵
   1. Dowell D,
   2. Haegerich TM,
   3. Chou R

   . CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep 2016;65:1–49.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Ballantyne JC,
   2. Sullivan MD,
   3. Kolodny A

   . Opioid dependence vs. addiction: a distinction without a difference? Arch Intern Med 2012;172:1342–3.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Højsted J,
   2. Nielsen PR,
   3. Guldstrand SK,
   4. Frich L,
   5. Sjøgren P

   . Classification and identification of opioid addiction in chronic pain patients. Eur J Pain 2010;14:1014–20.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Yanni LM,
   2. Weaver MF,
   3. Johnson BA,
   4. Morgan LA,
   5. Harrington SE,
   6. Ketchum JM

   . Management of chronic nonmalignant pain: a needs assessment in an internal medicine resident continuity clinic. J Opioid Manag 2008;4:201–11.

   OpenUrlPubMed
10. 10.↵
    1. Corrigan C,
    2. Desnick L,
    3. Marshall S,
    4. Bentoy N,
    5. Rosenblatt RA

    . What can we learn from first-year medical students' perceptions of pain in the primary care setting? Pain Med 2011;12:1216–22.

    OpenUrl
11. 11.↵
    1. Kolodny A,
    2. Courtwright DT,
    3. Hwang CS,
    4. et al

    . The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health 2015;36:559–74.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Ballantyne JC,
    2. LaForge KS

    . Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007;129:235–55.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Højsted J,
    2. Sjøgren P

    . Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 2007;11:490–518.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Vowles KE,
    2. McEntee MK,
    3. Julnes PS,
    4. Frohe T,
    5. Ney JP,
    6. van der Goes DN

    . Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 2015;156:569–76.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Becker WC,
    2. Fiellin DA,
    3. Merrill JO,
    4. et al

    . Opioid use disorder in the United States: insurance status and treatment access. Drug Alcohol Depend 2008;94:207–13.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Katz NP,
    2. Sherburne S,
    3. Beach M,
    4. et al

    . Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg 2003;97:1097–102.

    OpenUrlPubMedWeb of Science
17. 17.↵
    1. Ballantyne JC,
    2. Stannard C

    . New addiction criteria: diagnostic challenges persist in treating patients with opioids. Pain Clin Updates 2013;21:1–7.

    OpenUrl
18. 18.↵
    1. Starrels JL,
    2. Becker WC,
    3. Weiner MG,
    4. Li X,
    5. Heo M,
    6. Turner BJ

    . Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med 2011;26:958–64.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Turner JA,
    2. Saunders K,
    3. Shortreed SM,
    4. et al

    . Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results. J Gen Intern Med 2014;29:305–11.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Cheatle MD,
    2. Klocek JW,
    3. McLellan AT

    . Managing pain in high-risk patients within a patient-centered medical home. Transl Behav Med 2012;2:47–56.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Rudd RA,
    2. Paulozzi LJ,
    3. Bauer MJ,
    4. et al

    ; Centers for Disease Control and Prevention (CDC). Increases in heroin overdose deaths - 28 states, 2010 to 2012. MMWR Morb Mortal Wkly Rep 2014;63:849–54.

    OpenUrlPubMed
22. 22.↵
    1. Wiedemer NL,
    2. Harden PS,
    3. Arndt IO,
    4. Gallagher RM

    . The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med 2007;8:573–84.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Bart G

    . Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis 2012;31:207–25.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Pierce M,
    2. Bird SM,
    3. Hickman M,
    4. et al

    . Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England. Addiction 2015;111:298–308.

    OpenUrl
25. 25.↵
    1. Daitch D,
    2. Daitch J,
    3. Novinson D,
    4. Frey M,
    5. Mitnick C,
    6. Perfolizzi J Jr.

    . Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients. Pain Med 2014;15:2087–94.

    OpenUrl
26. 26.↵
    1. Roux P,
    2. Sullivan MA,
    3. Cohen J,
    4. et al

    . Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone. Pain 2013;154:1442–8.

    OpenUrl
27. 27.↵
    1. Earnshaw V,
    2. Smith L,
    3. Copenhaver M

    . Drug addiction stigma in the context of methadone maintenance therapy: an investigation into understudied sources of stigma. Int J Ment Health Addict 2013;11:110–22.

    OpenUrl
28. 28.↵
    Substance Abuse and Mental Health Services Administration. 2011 Opioid Treatment Program Survey: data on substance abuse treatment facilities with OTPs. BHSIS Series S-65, HHS publication no. (SMA) 14–4807. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013. Available from: http://www.samhsa.gov/data/sites/default/files/OTP2011_Web/OTP2011_Web/OTP2011_Web.pdf. Accessed June 26, 2016.
29. 29.↵
    1. Rosenblatt RA,
    2. Andrilla CH,
    3. Catlin M,
    4. Larson EH

    . Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann Fam Med 2015;13:23–6.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Westanmo A,
    2. Marshall P,
    3. Jones E,
    4. Burns K,
    5. Krebs EE

    . Opioid dose reduction in a VA health care system–implementation of a primary care population-level initiative. Pain Med 2015;16:1019–26.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Weimer MB,
    2. Hartung DM,
    3. Ahmed S,
    4. Nicolaidis C

    . A chronic opioid therapy dose reduction policy in primary care. Subst Abus 2016;37:141–7.

    OpenUrl
32. 32.↵
    Drug Addiction Treatment Act of 2000. Publ L No. 106–310, Stat 1101. Available from: http://www.samhsa.gov/medication-assisted-treatment/legislation-regulations-guidelines#DATA-2000. Accessed June 26, 2016.